Perrigo Company plc has grown revenue −3.6% a year over three years and −0.66% a year over five. Revenue growth, 3-year annual rate: −3.6% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: −0.66%, growth has slowed since the five-year average. Years of annual history on file: 14, FY2011 to FY2025, as filed.

PRGOPerrigo Company plc

Healthcare

$15.05-26% 1Y

$15.05

$9.0252 weeks$21.46

Is it growing?

Watch

Growth is fading: revenue shrinking (−4% year on year) and operating margin narrowing (−42.8 points).

2 to watch, 1 without data

Revenue trend−4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −1% a year.

Margin direction−42.8 points operating

Trailing-twelve-month operating margin, -36.3% now against 6.6% a year earlier.

All from SEC EDGAR, as of Jun 27, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PRGO growing?

Perrigo Company plc has grown revenue −3.6% a year over three years and −0.66% a year over five.

−3.6%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −0.66%
Revenue growth, 5-year rate · −3.6% over three · growth has slowed since the five-year average
Years of annual history on file: 14
Years of annual history on file · FY2011 to FY2025, as filed

Details›